SCLC
Ongoing protocols: click on the protocol for the inclusion and exclusion criteria (update 5/12/2018)
Non-metastatic stage
STIMULI (ETOP)
A Randomised Open-label Phase II Trial of Consolidation With Nivolumab and Ipilimumab in Limited-stage SCLC After Chemo-radiotherapy.
Metastatic stage
1st line
Currently no trials
2nd line
Currently no trials
3th line
Currently no trials
New trial in start-up: currently no new trials
2nd line
Currently no trials
3th line
Currently no trials
New trial in start-up: currently no new trials